Reaction

Impaired Self-Care reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,075 reports · 47 co-occurring drugs

As of the last recalculation, Impaired Self-Care appears in 2,075 FAERS reports alongside 47 co-occurring drug terms. The strongest observed disproportionality signal is LITHIUM CARBONATE (PRR 21.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Lithium Carbonate	36	21.6	21.7
Thiamine Hydrochloride	18	14.6	14.6
Regorafenib	16	13.9	13.9
Copper	52	12.4	12.4
Methylprednisolone Acetate	8	10.1	10.1
Oxybutynin Chloride	8	9.2	9.2
Primidone	9	8.9	8.9
Granisetron Hydrochloride	9	8.7	8.7
Granisetron	9	8.6	8.6
Risperidone	107	8.5	8.5
Lithium	21	8.4	8.4
Lithium Bromatum	21	8.4	8.4
Dimethyl Fumarate	98	8.3	8.3
Paliperidone Palmitate	26	8.2	8.2
Rivastigmine	15	8.0	8.0
Clozapine	91	7.6	7.6
Divalproex Sodium	34	7.4	7.4
Olanzapine	75	7.2	7.2
Liothyronine Sodium	6	6.9	6.9
Quetiapine	125	6.9	6.9
Sorafenib	14	6.8	6.8
Haloperidol	16	6.6	6.7
Haloperidol Lactate	16	6.5	6.5
Levodopa	7	5.8	5.8
Lurasidone Hydrochloride	12	5.8	5.8
Rasagiline Mesylate	6	5.4	5.4
Donepezil Hydrochloride	19	5.2	5.2
Memantine	7	5.1	5.1
Memantine Hydrochloride	7	5.1	5.1
Carbidopa And Levodopa	24	5.1	5.1
Brexpiprazole	8	4.8	4.9
Peginterferon Beta-1A	6	4.6	4.6
Interferon Beta-1A	84	4.5	4.5
Cariprazine	4	4.3	4.3
Hydrocodone Bitartrate And Acetaminophen	24	4.3	4.3
Paliperidone	9	3.9	3.9
Diclofenac Potassium	4	3.7	3.7
Natalizumab	64	3.6	3.6
Diclofenac Potassium, Film Coated	3	3.6	3.6
Diclofenac Potassium Tablets	3	3.6	3.6
Dalfampridine	25	3.5	3.5
Vemurafenib	4	3.3	3.3
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	9	2.9	2.9
Lenvatinib	9	2.8	2.8
Diroximel Fumarate	3	2.5	2.5
Valbenazine	5	2.0	2.0
Salicylic Acid	5	0.9	0.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.